FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Sunday

 

MS: Treatments to reverse myelin damage step closer with brain repair study































The new study takes treatment research into the area of reversing myelin damage. This picture shows myelin (in red) and myelin-producing cells (oligodendrocytes, in green).
Image credit: Queen's University Belfast

A breakthrough study looking at how the brain repairs itself could revolutionize treatments for multiple sclerosis. The research, performed on mice and tissue cultures, reveals for the first time that a type of cell involved in immune control also releases a protein that triggers regrowth of myelin.

The international study - led by Queen's University Belfast in Northern Ireland, United Kingdom - is published in the journal Nature Neuroscience.

Senior author Dr. Denise Fitzgerald - of the University's Wellcome-Wolfson Institute for Experimental Medicine - describes the findings as "an important step forward in understanding how the brain and spinal cord is naturally repaired."

Worldwide, more than 2.3 million people are affected by multiple sclerosis (MS) - a disease in which the immune system mistakenly attacks the tissue of the central nervous system, which consists of the brain, spinal cord, and optic nerves.

In MS, the immune system attacks and destroys myelin - the fatty, protective sheath that surrounds and insulates nerve fibers.

As the myelin damage increases, it disrupts the signals that travel to and from the brain along the affected nerve fibers. This results in a range of symptoms that include impaired mobility, extreme fatigue, vision problems, pain, and altered sensation.

Study takes research into area of reversing myelin damage
Although anyone can develop MS, it is the most common neurological disease in young adults and it affects two to three times more women than men.

There is no evidence that MS is hereditary, but it is thought that genes play a role, as well as certain environmental factors such as low vitamin D and smoking tobacco.

There is currently no cure for MS, although some approved drugs appear to reduce frequency of relapses and delay disease progression to some extent.

The researchers are excited about their discovery because it takes treatment research into the area of reversing myelin damage.

Dr. Fitzgerald has a personal as well as a professional interest in MS - when she was 21, she had to learn to walk again after experiencing a similar condition called transverse myelitis.

The study concerns a type of immune cell called T cells, which, in cases of MS, are known to cross over from the bloodstream into the central nervous system.

Dr. Fitzgerald and colleagues discovered that a subtype of T cells called regulatory T cells - which are already known to be involved in regulating the immune system - also have a role in promoting myelin regrowth.

The regulatory T cells promote myelin regrowth through their effect on oligodendrocytes - the cells that make myelin. The process of myelin regrowth requires oligodendrocyte progenitor cells to mature into oligodendrocyte cells.

Regulatory T cells also have a regenerative role
The researchers found that regulatory T cells release a protein that stimulates the differentiation of the progenitor cells into mature oligodendrocytes.

They showed that mice deficient in regulatory T cells showed substantially impaired myelin regeneration, which was restored when they transferred regulatory T cells into the mice.

Using cultured brain tissue, the researchers also showed that regulatory T cells "accelerated developmental myelination and remyelination, even in the absence of overt inflammation."

Story Source: The above story is based on materials provided by MEDICALNEWSTODAY
Note: Materials may be edited for content and length

Labels:



Go to Newer News Go to Older News